NYSE
According to Zyberno, AMETEK, Inc. (AME) is not a buy — GOOD BUSINESS (68/100) with a negative Margin of Safety of -40.2% and a Brina Gap of -9.6% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, AMETEK, Inc. (AME) trades at $243.67 against an estimated intrinsic value per share of $173.77 — a -40.2% Margin of Safety based on Owner Earnings of $1.70B TTM, projected at 13.8% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -9.6% weakens the case: based on the company's ROIC (13.1%) and reinvestment rate (38.1%), the business can fundamentally grow at 5.0% — but the current enterprise value implies the market expects 14.6%. This places AME in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of 6.3% annually.
Over the trailing twelve months, AME generated $1.70B in Owner Earnings. Capital was deployed as follows: $27.94M returned via share buybacks, $298.04M paid as dividends, $132.65M invested in capital expenditures. Reinvestment rate: 38.1%. Owner Earnings have grown at 13.8% annually over the trailing five years using log-linear regression.